Antigua and Barbuda vs Naoero: New cases tested for RR-/MDR-TB
Antigua and Barbuda
100.0%
in 2024
Naoero
100.0%
in 2023
Antigua and Barbuda rank
1st
Naoero rank
1st
New cases tested for RR-/MDR-TB over time
- Antigua and Barbuda
- Naoero
How they compare
Antigua and Barbuda currently reports 100.0% against 100.0% in Naoero, a difference of 0.0%.
Across all 8 years both countries report, Naoero has been ahead every year.
Antigua and Barbuda ranks 1st and Naoero ranks 1st of 192 countries.
Naoero has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.0% | 50.0% | 50.0% | Naoero |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Antigua and Barbuda or Naoero?
- Antigua and Barbuda, at 100.0% against 100.0% in Naoero as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Antigua and Barbuda and Naoero?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Naoero?
- 8 years are reported by both, from 2009 to 2021.
- How do Antigua and Barbuda and Naoero rank globally for new cases tested for rr-/mdr-tb?
- Antigua and Barbuda ranks 1st and Naoero ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.